Because MMP14 is upregulated in brain-infiltrating macrophages in Alzheimer disease, multiple sclerosis, and stroke (43), this promoter could be also used for gene therapy in noncancerous brain disorders accompanied by strong myeloid cell infiltration (14,44–49). The gene discussed is MMP14; the disease is multiple sclerosis.